Molecularly Imprinted Polymeric Nanoparticles as Drug Delivery System for Tenofovir, an Acyclic Nucleoside Phosphonate Antiviral.

A molecularly imprinted polymer of Tenofovir (1), an FDA-approved acyclic nucleoside phosphonate with antiviral activity, was synthesized using a non-covalent approach. A pre-polymerization complex was formed between (1) and DMAEMA and in-house synthetic N1 -[(2-methacryloyloxy)ethyl] thymine, with EGDMA as a cross-linker in an MeCN/H 2 O (9:1, 1:1) mixture as a porogen, giving an imprinting factor (IF) of 5.5 at 2.10 -5 mol/L. Binding parameters were determined by the Freundlich-Langmuir model, Q max and K a , and well as the particle morphology for MIP and NIP. Finally, the release profiles, for MIP and NIP, were obtained at 25 °C and 37 °C, which is body temperature, in a phosphate buffer saline, pH 7.4, mimicking the blood pH value, to determine the potential sustained release of our polymeric materials.